Avricore Health (AVCRF) Depreciation & Amortization (CF) (2014)

Avricore Health (AVCRF) posted quarterly Depreciation & Amortization (CF) of -$1810.7 for Q4 2014, up 92.77% sequentially from -$25041.0 in Q2 2014.

Avricore Health (AVCRF) Depreciation & Amortization (CF) (2014) Analysis & Trends

Avricore Health has disclosed Depreciation & Amortization (CF) across 1 years of filings, most recently posting -$1810.7 for Q4 2014.

In Q4 2014, Depreciation & Amortization (CF) changed N/A year-over-year to -$1810.7; the TTM figure through Sep 2015 stood at -$1810.7 (up 93.37% YoY), while the FY2019 annual figure was $4748.9, down 78.5% from the prior year.
Depreciation & Amortization (CF) rose to -$1810.7 in Q4 2014, from -$25041.0 in the prior quarter.
Over the last five years, Depreciation & Amortization (CF) for AVCRF reached as high as -$1810.7 in Q4 2014 and fell as low as -$25041.0 in Q2 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Dep. & Amort. (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn	36.00 Mn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn	306.00 Mn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn	193.00 Mn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn	37.68 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn	14.52 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn	67.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn	288.00 Mn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn	51.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn	13.16 Mn
10	Avricore Health	-	-	-	-

Download Data